Published in Vaccine Weekly, December 24th, 2008
"The protection provided by an aroA as well as structural and regulatory lipopolysaccharide (LPS) mutants of Salmonella enterica serovar Typhimurium against homologous and heterologous challenges was assessed in the murine model...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly